These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35373591)

  • 1. Comment on "Crotalidae Polyvalent Immune Fab and Cost-Effective Management of Hospital Admissions for Snakebites".
    Mullins ME; Schwarz ES; Liss DB; Devgun JM; Baumgartner KT
    Am Surg; 2022 Jun; 88(6):1379-1380. PubMed ID: 35373591
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Letter to the Editor Regarding 'Crotalidae Polyvalent Immune Fab (CroFab®) and Cost-Effective Management of Hospital Admissions for Snakebites'.
    Bowden MB; Christie DB
    Am Surg; 2022 Jun; 88(6):1383. PubMed ID: 35400172
    [No Abstract]   [Full Text] [Related]  

  • 3. Crotalidae Polyvalent Immune Fab and Cost-Effective Management of Hospital Admissions for Snakebites.
    Bowden MB; Christie DB; Hand KH; Montgomery A
    Am Surg; 2022 Mar; 88(3):368-371. PubMed ID: 34974712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crotalidae polyvalent immune Fab: in patients with North American crotaline envenomation.
    Keating GM
    BioDrugs; 2011 Apr; 25(2):69-76. PubMed ID: 21443271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment: severe anaphylactic reaction following crotalidae polyvalent immune fab (ovine) administration for copperhead snakebite.
    Mullins ME; Liss DB; Schwarz ES
    Ann Pharmacother; 2015 Apr; 49(4):496. PubMed ID: 25762655
    [No Abstract]   [Full Text] [Related]  

  • 6. Copperhead bites and Crotalidae polyvalent immune Fab (ovine): routine use requires evidence of improved outcomes.
    Caravati EM
    Ann Emerg Med; 2004 Feb; 43(2):207-8. PubMed ID: 14747810
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply: severe anaphylactic reaction following crotalidae polyvalent immune fab (ovine) administration for copperhead snakebite.
    Bush SP; Lepak MR
    Ann Pharmacother; 2015 Apr; 49(4):497-8. PubMed ID: 25762656
    [No Abstract]   [Full Text] [Related]  

  • 8. Crotalidae polyvalent immune Fab for the treatment of pediatric crotaline envenomation.
    Goto CS; Feng SY
    Pediatr Emerg Care; 2009 Apr; 25(4):273-9; quiz 280-2. PubMed ID: 19369845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe adverse drug reaction following Crotalidae Polyvalent Immune Fab (Ovine) administration for copperhead snakebite.
    Lepak MR; Bochenek SH; Bush SP
    Ann Pharmacother; 2015 Jan; 49(1):145-9. PubMed ID: 25341425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of South American rattlesnake (Crotalus durissus terrificus) envenomation with Crotalidae polyvalent immune Fab (CroFab™).
    Lynch MJ; Ritter SC; Cannon RD
    J Med Toxicol; 2011 Mar; 7(1):44-6. PubMed ID: 20658221
    [No Abstract]   [Full Text] [Related]  

  • 11. Rattlesnake Envenomation in the Third Trimester of Pregnancy.
    Ghosh N; Henderson JA; Kim HG; Ancar FM
    Obstet Gynecol; 2018 Sep; 132(3):682-686. PubMed ID: 30095759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Tissue Loss After Agkistrodon Snakebite: Appropriate Use of Crotalidae-Fab Antivenin.
    Larson KW; Schaefer KR; Austin C; Norton R; Finley PJ
    J Trauma Nurs; 2016; 23(3):169-72. PubMed ID: 27163225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antivenom Does Not Cause Snakebite Complications, Withholding It Does.
    J Gerardo C; Godfrey AW; Greene S
    Am Surg; 2022 Jun; 88(6):1381-1382. PubMed ID: 35331015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Response to "The Efficacy of Crotalidae Polyvalent Immune Fab (Ovine) Antivenom Versus Placebo Plus Optional Rescue Therapy on Recovery from Copperhead Snake Envenomation".
    Chiang W; Harding SA; Tassin SA; Nguyen V; Su M
    Ann Emerg Med; 2017 Dec; 70(6):930-931. PubMed ID: 29157700
    [No Abstract]   [Full Text] [Related]  

  • 15. Presumed Copperhead Snakebite and Antivenom Administration in the Third Trimester.
    Yano J; Zerden M; German B
    Wilderness Environ Med; 2019 Dec; 30(4):446-449. PubMed ID: 31699647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational use of crotalidae polyvalent immune Fab (ovine) in the management of crotaline bite.
    Yip L
    Ann Emerg Med; 2002 Jun; 39(6):648-50. PubMed ID: 12023708
    [No Abstract]   [Full Text] [Related]  

  • 17. First new management for poisonous snakebites in more than 50 years is now available. Biotechnology product provides safe and effective therapy for poisonous snake bites.
    Clin Nurse Spec; 2001 May; 15(3):121-3. PubMed ID: 11855461
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of US crotalidae bites: comparisons of serum and globulin-based polyvalent and antigen-binding fragment antivenins.
    Seger D; Kahn S; Krenzelok EP
    Toxicol Rev; 2005; 24(4):217-27. PubMed ID: 16499404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hypersensitivity reaction from administration of crotalidae immune F(ab')2 antivenom.
    Ontiveros S; Clark RF; Minns AB
    Clin Toxicol (Phila); 2021 Jul; 59(7):676. PubMed ID: 33155844
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of delayed use of crotalidae polyvalent immune Fab (ovine) antivenom.
    Bebarta V; Dart RC
    J Toxicol Clin Toxicol; 2004; 42(3):321-4. PubMed ID: 15362603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.